Gallus Biopharmaceuticals Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 180

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

  • Investments
  • 3

Gallus Biopharmaceuticals General Information

Description

Manufacturer and supplier of clinical and commercial bulk biologics to the biopharmaceutical industry in the United States and internationally. The company provides process development, analytical development, process validation, cell banking, stability testing, QA/QC and regulatory support solutions.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 4766 La Guardia Drive
  • Berkeley, MO 63134
  • United States
+1 (314)
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Acquirer
Corporate Office
  • 4766 La Guardia Drive
  • Berkeley, MO 63134
  • United States
+1 (314)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gallus Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Gallus Biopharmaceuticals‘s full profile, request access.

Request a free trial

Gallus Biopharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer and supplier of clinical and commercial bulk biologics to the biopharmaceutical industry in the United Stat
Biotechnology
Berkeley, MO
180 As of 2011

Albany, NY
 

Martinsried, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Gallus Biopharmaceuticals Competitors (6)

One of Gallus Biopharmaceuticals’s 6 competitors is Curia, a Private Equity-Backed company based in Albany, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Curia Private Equity-Backed Albany, NY
Coriolis Pharma Venture Capital-Backed Martinsried, Germany
CordenPharma Private Equity-Backed Basel, Switzerland
Novonesis Corporation Lyngby, Denmark
Symbiosis Pharmaceutical Services Venture Capital-Backed Stirling, United Kingdom
To view Gallus Biopharmaceuticals’s complete competitors history, request access »

Gallus Biopharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gallus Biopharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Gallus Biopharmaceuticals‘s full profile, request access.

Request a free trial

Gallus Biopharmaceuticals Investments & Acquisitions (3)

Gallus Biopharmaceuticals’s most recent deal was a Buyout/LBO with Laureate Biopharmaceutical Services. The deal was made on 01-Oct-2013.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Laureate Biopharmaceutical Services 01-Oct-2013 Buyout/LBO Pharmaceuticals
Centocor Biologics (Manufacturing Plant) 19-May-2011 Buyout/LBO Buildings and Property
Centocor Biologics 13-May-2011 Merger/Acquisition Biotechnology
To view Gallus Biopharmaceuticals’s complete investments and acquisitions history, request access »

Gallus Biopharmaceuticals FAQs

  • When was Gallus Biopharmaceuticals founded?

    Gallus Biopharmaceuticals was founded in 2010.

  • Where is Gallus Biopharmaceuticals headquartered?

    Gallus Biopharmaceuticals is headquartered in Berkeley, MO.

  • What is the size of Gallus Biopharmaceuticals?

    Gallus Biopharmaceuticals has 180 total employees.

  • What industry is Gallus Biopharmaceuticals in?

    Gallus Biopharmaceuticals’s primary industry is Biotechnology.

  • Is Gallus Biopharmaceuticals a private or public company?

    Gallus Biopharmaceuticals is a Private company.

  • What is the current valuation of Gallus Biopharmaceuticals?

    The current valuation of Gallus Biopharmaceuticals is .

  • What is Gallus Biopharmaceuticals’s current revenue?

    The current revenue for Gallus Biopharmaceuticals is .

  • Who are Gallus Biopharmaceuticals’s investors?

    Ridgemont Equity Partners has invested in Gallus Biopharmaceuticals.

  • Who are Gallus Biopharmaceuticals’s competitors?

    Curia, Coriolis Pharma, CordenPharma, Novonesis, and Symbiosis Pharmaceutical Services are some of the 6 competitors of Gallus Biopharmaceuticals.

  • When was Gallus Biopharmaceuticals acquired?

    Gallus Biopharmaceuticals was acquired on 30-Sep-2014.

  • Who acquired Gallus Biopharmaceuticals?

    Gallus Biopharmaceuticals was acquired by Patheon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process